AGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised platform trial letter. (2021)

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13063-021-05458-4

PubMed Identifier: 34311777

Publication URI: http://europepmc.org/abstract/MED/34311777

Type: Journal Article/Review

Volume: 22

Parent Publication: Trials

Issue: 1

ISSN: 1745-6215